Evidence shows that a substantial proportion of patients with COVID-19 experiences long-
term consequences of the disease, but the predisposing factors are poorly understood. We …

Background The long‐term sequalae of COVID‐19 remain poorly characterized. We
assessed persistent symptoms in previously hospitalized patients with COVID‐19 and …

Background The frequency of asymptomatic SARS-CoV-2 infection with viral spread is
unclear. Here, we investigated asymptomatic SARS-CoV-2 infection development and …

Survivors to COVID-19 have described long-term symptoms after acute disease. These
signs constitute a heterogeneous group named long COVID or persistent COVID. The aim of …

Objectives Persistence of COVID-19 symptoms in nonhospitalized individuals beyond a few
months has not been well characterized. In this longitudinal study from the Faroe Islands, we …

Summary Background At least 5–10% of subjects surviving COVID-19 develop the post-
COVID-19 condition (PCC) or" Long COVID". The clinical presentation of PCC is …

Background Evidence on post-acute sequelae of SARS-CoV-2 (PASC) has shown
inconsistent findings. This study aimed to generate coherent evidence on the post-acute …

The enduring impact of COVID-19 on patients has been examined in recent studies, leading
to the description of Long-COVID. We report the lasting symptom burden of COVID-19 …

ABSTRACT Novel coronavirus disease 2019 (COVID-19), caused by novel coronavirus
SARS-CoV-2, has spread globally since the end of 2019. Asymptomatic carriers are of great …

Objectives Most reports describing the characteristics of patients hospitalised with COVID-19
lack a comparator group. We compared clinical characteristics, symptoms, and outcomes of …